chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pyrexia
Clinical narrative: tiredness; Chills; Fever; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 16Apr2021 at 08:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19.  The patient did not have allergies to medications, food, or other products. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), fluticasone propionate (MANUFACTURER UNKNOWN) and paracetamol (TYLENOL), all for unknown indication, from an unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED6955) via an unspecified route of administration in the left arm on an unknown date in Mar2021 at 08:45 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 08:45, the patient still experienced tiredness, chills and fever. Chills and fever at least twice a day. The patient was told that it should only last for 2 days, but it was day 4. Therapeutic measures were not taken as a result of the event.  Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events tiredness, chills and fever was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia
Clinical narrative: Sleeplessness. Have been awaking at 3:30 AM since first vaccine.; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unspecified date in 2021 and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillun (Penicillin allergy). Concomitant medications were not reported.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient experienced sleeplessness and had been waking up at 03:30 since the first vaccine. The event did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sleeplessness was unknown at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pruritus, Urticaria
Clinical narrative: Hives; Itching all over body in random spots; Occasional stinging sensation mainly on arms; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included Wolff-Parkinson-white syndrome (WPW) and neurocardiogenic syncope. The patient previously took paracetamol; oxycodone hydrochloride (PERCOCET) on an unknown date and experienced drug allergy.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included cetirizine hydrochloride (ZYRTEC), butalbital, caffeine, paracetamol (FIORICET), fludrocortisone (MANUFACTURER UNKNOWN) and desogestrel, ethinylestradiol (APRI) all started from an unknown date for an unknown indication and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 05Apr2021 at 17:00, the patient experienced hives, itching all over body in random spots and occasional stinging sensation mainly on arms. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events hives, itching all over body in random spots and occasional stinging sensation mainly on arms were recovered on an unknown date in Apr2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN8737) via an unspecified route of administration in the left arm on 02Apr2021 at 13:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN208) via an unspecified route of administration in the left arm on 19Mar2021 at 13:15 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. On 02Apr2021 at 13:15, the patient experienced inappropriate schedule of vaccine administered. On 05Apr2021 at 13:15, the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.  The clinical outcome of the event tinnitus was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Flushing, Heart rate increased, Skin warm
Clinical narrative: At 10:55 AM, within five minutes of the vaccine being administered (at 10:50 AM), I felt light headed.  Around 40-50minutes later (around 11:45-11:55AM) I felt light headed; my face felt hot; At 10:55 AM, within five minutes of the vaccine being administered (at 10:50 AM), my face felt flushed.  Around 40-50minutes later (around 11:45-11:55AM) I felt flushed.; At 10:55 AM, within five minutes of the vaccine being administered (at 10:50 AM),  I had a rapid heart beat. It lasted for about ten minutes (ended around 11:05 AM)and I left to go home. , and a rapid heart beat for 15 minutes; This is a spontaneous report from a contactable consumer, the patient. A 25-year-old female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0170) via an unspecified route of administration in the left arm on 20Apr2021 at 10:45 (at the age of 25-year-old) as a single dose for COVID-19 immunisation. Medical history included drug allergy (anything in the -cycline family). The patient previously took doxycycline and experienced allergy to the medication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. On 20Apr2021 at 10:55, within five minutes of the vaccine being administered, the patient felt light headed, the face felt hot and flushed, and had a rapid heartbeat and it lasted for about ten minutes (ended around 11:05 AM). Around 40-50 minutes later, the patient again felt light headed, flushed and a rapid heart beat for 15 minutes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events light headedness, hot and flushed face and rapid heart beat was resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Paraesthesia, Paraesthesia oral
Clinical narrative: About 8 hours after start feeling dizzy; hard to breath; Tingling around lips fingers and toes; Tingling around lips fingers and toes; This is a spontaneous report received from a contactable consumer (Patient). A 16-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EW0189), Solution for injection, via an unspecified route of administration, administered in Arm Right on 17Apr2021 08:00 (at the age of 16-year-old) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received unspecified medication in two weeks.The patient was not diagnosed with COVID-19 Prior to vaccination. The patient had not been tested for COVID-19 Since the vaccination. The patient previously took codeine and experienced codeine allergy. On 17Apr2021 20:00, about 8 hours after start feeling dizzy, hard to breath, tingling around lips fingers and toes. Benadryl and IV fluid were received as a therapeutic measure to treat adverse events. Ae resulted in emergency room/department or urgent care visit. The events were recovered on an unspecified date in Apr2021.   No follow-up attempts are possible. No further information is expected.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 18Apr2021 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included dysautonomia. The patient was allergic to many antibiotics and metals. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), melatonin (MANUFACTURER UNKNOWN), fluoxetine hydrochloride (PROZAC), levocetirizine dihydrochloride (XYZAL) and ciclosporin (RESTASIS), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 28Mar2021 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 12:30, the patient experienced uncontrollable bloody nose. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event uncontrollable bloody nose was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Disease recurrence, Gout
Clinical narrative: right foot gout flare up, then approx 2 days later foot was better and then the right knee gout flare up, this stayed for a few days, then two days ago from today, gout flare up in right foot and knee is better.; get gout flare ups but have not had one in a long time/right foot gout flare up then approx 2 days later foot was better and then the right knee gout flare up; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ep7533) via an unspecified route of administration in the left arm on 11Apr2021 at 16:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included gout flare and he did not have one in a long time. The patient had no known allergies to food, medications or other products. The patient did not take any concomitant medications . Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 12Apr2021 at 06:00, the patient experienced right foot gout flared up. Then approximately 2 days later foot was better and then the right knee gout flared up. This stayed for a few days, then two days ago from today, gout flared up in right foot and knee was better. He had not had a gout flare up in a long time. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19.The clinical outcome of the event right foot gout flared , then approximately 2 days later foot was better and then the right knee gout flared up was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Losing much more hair than normal the last 4 days.; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 14Apr2021 at 15:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Other medical history was reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021, the patient experienced losing much more hair than normal the last 4 days, to the point that the patient must clean the brush 2-3 times while brushing the hair when the patient generally only lost a few strands. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event losing much more hair than normal the last 4 days was not recovered at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Body temperature fluctuation, Change in sustained attention, Headache
Clinical narrative: Severe headache; Muscle pain; Joint pain; occasional spasms; Temperature that fluctuated between 99-101.2 for approximately 15 hours; Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally; Very drowsy still after sleeping on and off for over 30 hours.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 51-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD and basal cell nevus syndrome (history of numerous basal cell cx's). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 50 mg daily and naproxen sodium (ALEVE) 1 pill 2 nights before; both from unknown dates for unspecified indications. The patient previously took levofloxacin (LEVAQUIN) and fluorouracil (EFUDEX); both on unknown dates for unspecified indications and experienced drug allergy. On an unknown date in 2021, the patient experienced severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab test and procedure which included body temperature and result was shown as 99-101.2 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Myalgia, Somnolence
Clinical narrative: Severe headache; Muscle pain; Joint pain; occasional spasms; Temperature that fluctuated between 99-101.2 for approximately 15 hours; Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally; Very drowsy still after sleeping on and off for over 30 hours.; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 29Mar2021 at 10:00 (at the age of 51-years-old) and a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 19Apr2021 at 10:30 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included ADHD and basal cell nevus syndrome (history of numerous basal cell cx's). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included lisdexamfetamine mesilate (VYVANSE) 50 mg daily and naproxen sodium (ALEVE) 1 pill 2 nights before; both from unknown dates for unspecified indications. The patient previously took levofloxacin (LEVAQUIN) and fluorouracil (EFUDEX); both on unknown dates for unspecified indications and experienced drug allergy. On an unknown date in 2021, the patient experienced severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent lab test and procedure which included body temperature and result was shown as 99-101.2 (units unspecified). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events severe headache, muscle and joint pain with occasional spasms and temperature that fluctuated between 99-101.2 for approximately 15 hours. Attempting to work, but finding, have to triple check all typing as not able to focus and type correctly as can normally, very drowsy still after sleeping on and off for over 30 hours were resolving at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Chills; Fever; Body aches and and pain all over; Pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 76-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 19Apr2021 at 01:15 (at the age of 76-year-old) as a single dose for COVID-19 immunisation. The medical history included diabetes and heart condition. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The patient received  medications( reported as too many to list) within two weeks of vaccination. The patient previously took prochlorperazine (COMPAZINE) on an unknown date and experienced allergy. On 20Apr2021 at 01:00, the patient experienced chills, fever, pain at injection site, body aches and pain all over. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, fever, pain at injection site, body aches and pain all over  were recovered un an unknown date in Apr2021.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic, Skin exfoliation
Clinical narrative: This is a spontaneous report from a contactable physician, the patient. A forty-two-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 06Apr2021 at 13:00 (at the age of 42-years-old) as a single dose. Medical history included uterine bleeding, Hodgkin's lymphoma x 3 status post autologous bone marrow transplant, anemia, gastric sleeve surgery, chronic rhinitis, high Thyroid Stimulating Hormone (TSH). The patient had no allergies to medications, food, or other products. Concomitant medications included levothyroxine sodium (SYNTHROID), norethendrone (MANUFACTURER UNKNOWN) and ferrous fumarate (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates.  Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021, the patient had itchy rash on neck and skin peeling on face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included self-treatment with steroid cream (fluocinonide). The clinical outcome of the events itchy rash on neck and skin peeling on face were not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus, Vertigo
Clinical narrative: Vertigo started on April 20th; Tinnitus started on April 18th; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 15Apr2021 at 20:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulfonamide allergy to sulfa drugs and seasonal allergy.  Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Concomitant medications included loratadine (CLARITIN) for an unknown indication from an unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 27Mar2021 at 14:45 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 18Apr2021 at 13:15, the patient experienced tinnitus and vertigo started on 20Apr2021.  Therapeutic measures were taken as a result of events and included treatment with unspecified exams and prescription for meclizine. Since the vaccination, the patient had not been tested for COVID-19. The event resulted in emergency room/department or urgent care. The clinical outcome of the events tinnitus started on 18Apr2021 and vertigo started on 20Apr2021 were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 37.0
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Ipsilateral left side clavicular lymphadenopathy; This is a spontaneous report from a contactable nurse, the patient. A 37-year-old unknown gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the left arm on 26Mar2021 at 09:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and hypothyroidism. The patient had known allergies to sulfa. Concomitant medications included escitalopram oxalate (LEXAPRO) and levothyroxine sodium (SYNTHROID); both taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 02Apr2021 at 09:00, the patient experienced ipsilateral left side clavicular lymphadenopathy. The event resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ipsilateral left side clavicular lymphadenopathy was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: This is a spontaneous report from a contactable consumer, the patient. A 57-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration on 15Apr2021 at 09:15 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known drug allergy (NKDA). The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in Apr2021 the patient experienced left supraclavicular lymphadenopathy. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event left supraclavicular lymphadenopathy was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Tinnitus; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 04Apr2021 at 14:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within two weeks prior to the COVID-19 vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 04:30, the patient experienced tinnitus. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event tinnitus was not resolved at the time of this report.  No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Pain in extremity, Vertigo
Clinical narrative: Vertigo; Pain in right side of stomach; Dizziness; Arm pain (now subsided); This is a spontaneous report from a contactable consumer, the patient. A 64-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 64-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had some known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 16Apr2021 at 12:00, the patient experienced vertigo, dizziness, arm pain (now subsided) and pain in right side of stomach. Since the vaccination, the patient had not been tested for COVID-19. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of event arm pain, vertigo, dizziness and pain in right side of stomach were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Limb discomfort, Peripheral swelling, SARS-CoV-2 test
Clinical narrative: left forearm /  Area was swollen, red and hot / visible patch on left forearm; left forearm /  Area was swollen, red and hot / visible patch on left forearm; left forearm /  Area was swollen, red and hot / Right forearm was also hot and irritated; Right forearm was also hot and irritated; This is a spontaneous report from a contactable healthcare professional, the patient. A 42-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13Apr2021 at 16:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. It was unknown if the patient was pregnant. The patient had allergy to chicken meat and buckwheat. Concomitant medications included montelukast sodium (SINGULAIR), taken for an unspecified indication from an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. On 19Apr2021 at 09:00, 6 days post vaccination, the patient experienced delayed reaction on the left forearm, the area was swollen, red and hot. The right forearm was also hot and irritated but did not have a visible patch like left forearm. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events left forearm area was swollen, red and hot with a visible patch and right forearm was hot and irritated were resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: Slight sore throat; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 15:30 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient experienced slight sore throat for over 7 days now (at the time of report). The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event slight sore throat was not resolved at the time of the report.  No follow-up attempts are needed. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Mild case of shingles; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 09:15 (at the age of 45-years-old) as single dose for COVID-19 immunisation. The medical history of the patient included ulcerative colitis. The patient had no known allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other medication within two weeks prior to the COVID-19 vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 26Feb2021 at 09:45 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccination. On 09Apr2021, the patient experienced a mild case of shingles 2 weeks after the second vaccine. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event mild case of shingles was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Erythema, Fatigue, Glossodynia, Oropharyngeal pain
Clinical narrative: horrible sore throat with white spots & red, like strep throat; horrible sore throat with white spots & red, like strep throat; Sore on side of tongue; tired/ fatigue; no energy; body aches; pain in opposite right arm; itching in opposite right arm/ Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; This is a spontaneous report from a contactable Other-HCP (patient). A 59-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 17Mar2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, known allergies: Penicillin and shellfish. The patient's concomitant medications were not reported. The patient previously took Aleve, Novocaine and septocaine and experienced known allergies. The patient was not pregnant at time of vaccination. Th patient was not received other vaccine in four weeks. The patient was not received covid prior vaccination. The patient has not been tested covid post vaccination. On 17Mar2021, after first dose, the patient had horrible sore throat with white spots & red, like strep throat. The patient had Sore on side of tongue, gone in 2 days. Tired, no energy, fatigue, body aches through out. On an unknown date in Mar2021 (1 week later), the patient had pain, itching in opposite right arm exactly where shot was given in left arm. Redness and slight swelling, itchiness at first injection. The patient did not receive treatment for all events. The outcome of the event of Sore on side of tongue was recovered on 19Mar2021 and other events was recovering.  The lot number for the vaccine, bnt162b2 was not provided and will be requested during follow up.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pain in extremity, Pharyngitis streptococcal, Pruritus, Swelling
Clinical narrative: horrible sore throat with white spots & red, like strep throat; horrible sore throat with white spots & red, like strep throat; Sore on side of tongue; tired/ fatigue; no energy; body aches; pain in opposite right arm; itching in opposite right arm/ Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; Redness and slight swelling, itchiness at first injection; This is a spontaneous report from a contactable Other-HCP (patient). A 59-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in arm left on 17Mar2021 (at the age of 59-years-old) as dose 1, single for COVID-19 immunisation. Medical history included asthma, known allergies: Penicillin and shellfish. The patient's concomitant medications were not reported. The patient previously took Aleve, Novocaine and septocaine and experienced known allergies. The patient was not pregnant at time of vaccination. Th patient was not received other vaccine in four weeks. The patient was not received covid prior vaccination. The patient has not been tested covid post vaccination. On 17Mar2021, after first dose, the patient had horrible sore throat with white spots & red, like strep throat. The patient had Sore on side of tongue, gone in 2 days. Tired, no energy, fatigue, body aches through out. On an unknown date in Mar2021 (1 week later), the patient had pain, itching in opposite right arm exactly where shot was given in left arm. Redness and slight swelling, itchiness at first injection. The patient did not receive treatment for all events. The outcome of the event of Sore on side of tongue was recovered on 19Mar2021 and other events was recovering.  The lot number for the vaccine, bnt162b2 was not provided and will be requested during follow up.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate increased, Hypoaesthesia, Insomnia, Palpitations, Paraesthesia
Clinical narrative: Numbness and tingling in arms and legs; Started with dead arm immediately after shot. Moved to left leg, then other side of the body a few days later.; Numbness and tingling in arms and legs.; Rapid heart rate; Palpitations; Inability to sleep.; This is a spontaneous report from a contactable other healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 01Apr2021 at 15:30 (at the age of 29-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021, the patient experienced numbness and tingling in arms and legs, started with dead arm immediately after the shot. It moved to left leg and On an unknown date of Apr2021,  a few days later, it moved to other side of the body. The patient also experienced rapid heart rate and palpitations and inability to sleep. The events resulted in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events- numbness and tingling in arms and legs, started with dead arm immediately after the shot and then moved to left leg, moved to the other side of the body, rapid heart rate, palpitations and inability to sleep was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Swelling face
Clinical narrative: Facial swelling; Redness and hot to touch on left side of face only.; Hot to touch on left side of face only.; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. Medical history included bipolar disorder and penicillin allergy. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Concomitant medications included lithium (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN) and fluoxetine hydrochloride (PROZAC); all from unknown dates for unspecified indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 23mar2021 (at the age of 42-years-old), as a single dose for COVID-19 immunisation. On 18Apr2021 at 04:00, the patient experienced facial swelling accompanied with redness and hot to touch on left side of face only. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events facial swelling accompanied with redness and hot to touch on left side of face only were not resolved at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I have shingles and I have never had it before; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the arm left on 29Mar2021 at 13:00 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 08Mar2021 at 13:00 (at the age of 36-years-old) as a single dose for COVID-19 immunisation. On 08Apr2021 at 13:00, the patient experienced shingles which the patient never had before. The adverse event resulted in emergency room/department or urgent care. The patient received antibiotic (unspecified) as treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event shingles was not recovered at the time of this report.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Oral herpes
Clinical narrative: Multiple fever blisters; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 13Apr2021 at 02:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Concomitant medications included citalopram (MANUFACTURER UNKNOWN) from an unknown date for unknown indication. On 15Apr2021, the patient experienced multiple fever blisters. The patient did not have a fever blister in 20 years or more. He had three since the shot. No therapeutic measures were taken for the reported events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the multiple fever blisters was recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.